Redmile Group LLC 13D/13G Filings for Beam Therapeutics Inc. (BEAM)

Redmile Group LLC 13D and 13G filings for Beam Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
5:07 pm
Sale		 2021-12-31 13G Beam Therapeutics Inc.
BEAM		 Redmile Group LLC 1,885,850
2.800%		 -1,892,412decrease
(-50.09%)		 Filing
2021-02-16
4:06 pm
Purchase		 2020-12-31 13G Beam Therapeutics Inc.
BEAM		 Redmile Group LLC 3,778,262
6.500%		 3,778,262increase
(New Position)		 Filing